28 cannabis-related research grants have been funded by state cannabis taxes and liquor license fees in the last 3 years alone.
GB Sciences are looking for international suppliers that produce minor cannabinoids and terpenes to ensure that it can expand testing beyond their planned, initial Phase 0 Trial.
Our knowledge of the cannabinoids and endogenous system through which they act has grown considerably in the last quarter of a century but transforming that knowledge into new drugs remains challenging.
Eye drops developed by UBC researchers could one day treat glaucoma while you sleep – helping to heal a condition that is one of the leading causes of blindness around the world.
Medical cannabis and marijuana extracts should not be used for the treatment of obstructive sleep apnea, according to a statement from the American Academy of Sleep Medicine.
A clinical trial centered at the Children’s Hospital of Philadelphia is hoping to find evidence that cannabinoids can help treat pediatric autism.
The trial will help distinguish between multiple formulations based on various measures, including pharmacological and pharmacodynamic measures that may be predictive of drug efficacy.
The company behind the study hopes to complete their study evaluating the use of cannabis oil for treating chronic pain by fall 2018.
Human brain imaging clinical trials are already underway for a proprietary cannabinoid formulation to treat a major condition.